Topic: Heart failure - Primary Care
Monday, 21 November 2016
A number of drug classes are used in the treatment of patients with heart failure. This illustrated Back to Basics poster describes the various drugs and their mechanisms of action to give health care professionals and their patients a greater understanding of heart failure management and where sacubitril/valsartan fits into the picture.
Category: Back to Basics
Tuesday, 10 April 2018
Heart failure (HF) is a devastating clinical syndrome characterised by a constellation of symptoms and signs in the presence of reduced cardiac function. Comorbidity is almost inherent as HF is often the culmination of chronic disease processes such as ischaemic heart disease, hypertension and valve disease and its treatment may precipitate comorbidities such as gout, erectile dysfunction (ED) and acute kidney injury (AKI).
Tuesday, 26 April 2016
The outlook is bleak for patients with untreated or suboptimally treated heart failure (HF). Conversely, optimising management (HF) improves patient survival and reduces hospital admissions. However, standards of care continue to vary, and many HF patients are still not receiving recommended therapy with disease-modifying drugs or specialist input to their care. Outcomes will only improve for all our HF patients if evidence-based clinical guidelines are implemented throughout the NHS.
Thursday, 06 April 2017
The recent British Society for Heart Failure meeting included presentations from some of the UK’s leading experts in heart failure. This report focuses on some of the topics that will be useful to professionals in primary care with an interest in heart failure management.
Thursday, 28 April 2016
Cardiovascular disease (CVD) remains a national priority and primary care has a pivotal role in successfully addressing this urgent issue. This was the key message of Issues & Answers in Cardiovascular Disease 2015 conference, which participants and faculty said was the 'most successful' in the series to date.
Tuesday, 23 January 2018
Ischaemic or coronary heart disease is the single leading cause of death in any Western population but more critically is one of the leading causes of premature deaths (i.e. deaths 75 years) in both men and women. There are numerous risk factors for ischaemic heart disease and understanding these and other comorbidities is critical to achieving optimal outcomes.
Friday, 30 June 2017
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event and take advantage of our Early Bird discount.
Monday, 06 February 2017
‘Issues & Answers in Cardiovascular Disease’ is the leading UK cardiovascular conferences for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 6 hours CPD credits. Read the highlights from the 2016 conference and access presentation slides here.
Friday, 09 June 2017
This report provides highlights from the BSH Heart Failure Day for Revalidation and Training in March. The meeting featured the latest in HF management and practice including sessions on new trials, guidelines and an update on diabetic drugs, and other important areas. Two ‘Meet the Expert’ sessions looked at iron deficiency in chronic HF and ivabradine in the rehospitalised patient.
Friday, 23 February 2018
Stories in this Evidence in Practice include: Health survey for England, 2016: The good and the bad news Healthy lifestyle changes have a long-term benefit for type 2 diabetes prevention Weight loss diets reduce the risk of premature death for people with obesity Very low calorie diet can achieve a remission of Type 2 Diabetes Dash diet plus sodium reduction lowers systolic blood pressure Long-term follow-up underscores benefits of lowering LDL-C in CVD primary prevention Blood pressure self-monitoring is more effective with professional support AF and other chronic conditions = higher risk of death Clinical trials underestimate the real-world impact of Atherosclerotic CVD The burden of heart failure continues to rise in the UK
Category: Evidence in Practice